| Literature DB >> 28916114 |
E Héron1, T Bourcier2.
Abstract
Episcleritis is generally a benign disease with a self-limited course, while scleritis is a severe ocular condition due to a risk of impaired vision in one-fifth of patients and its association with systemic diseases in one third of them. Infectious scleritis, representing 8 % of the etiologies, is mainly of herpetic origin (varicella zoster and herpes simplex viruses). A systemic autoimmune disease is observed in roughly 30 % of scleritis patients: inflammatory rheumatisms (15 %), firstly rheumatoid polyarthritis, systemic vasculitides (8 %), mainly granulomatosis with polyangiitis (Wegener's) and polychondritis, and less often inflammatory bowel disease and systemic lupus erythematosus. Among the different types of scleritis, a clear distinction exists between necrotizing forms leading to decreased vision in 50 % of the cases and associated with systemic diseases in the vast majority, and non-necrotizing forms (either diffuse or nodular), with a better prognosis. However, recent publications show that necrotizing forms are much less frequent nowadays (around 5 % of the total), probably due to therapeutic innovations and progress made during the last 20 years. The medical management of scleritis requires collaboration between ophthalmologists and internists (or rheumatologists).Entities:
Keywords: Complication; Episcleritis; Infection; Maladie systémique; Scleritis; Sclérite; Systemic disease; Traitement; Treatment; Épisclérite
Mesh:
Year: 2017 PMID: 28916114 DOI: 10.1016/j.jfo.2017.04.007
Source DB: PubMed Journal: J Fr Ophtalmol ISSN: 0181-5512 Impact factor: 0.818